GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
09:43 Oct 17, 2019 |
English to Polish translations [PRO] Bus/Financial - Business/Commerce (general) | |||||
---|---|---|---|---|---|
|
| ||||
| Selected response from: Frank Szmulowicz, Ph. D. United States Local time: 19:24 | ||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
2 +1 | działania na rzecz popularyzacji leku |
| ||
2 | rzecznictwo |
|
Summary of reference entries provided | |||
---|---|---|---|
poparcie lub obrona |
|
działania na rzecz popularyzacji leku Explanation: Patient Input Impact on Drug Commercialization Pre- and post-product launch advocacy relations activities historically consist of identifying appropriate ways industry and patient groups work together to address their shared interests, including use of a medication. In general, unmet needs fall into these categories: Disease awareness. What do patients and providers know about a particular disease or condition? Patients with less well-known diseases and conditions often are the true experts. Even their doctors learn from them. Those with more common diseases face other challenges, including stigma. Lung cancer is an excellent example. Lung cancer patients may not be offered support and treatment even when new effective treatments are available because they are blamed for their illness. Improvement in treatment. How well does the new product treat what patients care about? How does a drug’s efficacy impact treatment decision making and patient choice? What tools and resources do patients need to have informed conversations with their HCPs? Activating patients. What shapes the ability and willingness of patients to embrace innovation, participate in treatment decision making, and adhere to treatment regimens? Increasingly, patients embrace the chance to take responsibility for choosing their treatments and managing their illness. Still, others are not ready and willing; how can advocacy and industry collaborate to help? Channels and messaging for reaching patients. How and where do patients receive information? What is required to help them make informed choices and how can underserved populations be included? With so much noise online, how do we ensure patients receive credible information? Access barriers. If patients can’t afford a medication, what systems must be in place to ensure appropriate patients are able to access it? https://www.pm360online.com/can-advocacy-relations-benefit-l... |
| |
Login to enter a peer comment (or grade) |
rzecznictwo Explanation: Napisałabym krócej, po prostu rzecznictwo. W poniższym dokumencie jest bardzo ładnie opisana definicja– co prawda, w kontekście bibliotek, ale myślę, że tutaj też by pasowało. https://issuu.com/publikacjefrsi/docs/rzecznictwo |
| |
Login to enter a peer comment (or grade) |
23 mins peer agreement (net): +1 |
Reference: poparcie lub obrona Reference information: ale nie wiem czego :-) |
| |
Login to enter a peer comment (or grade) |
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.